These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23751350)

  • 1. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
    Springer J; Tschirner A; Hartman K; von Haehling S; Anker SD; Doehner W
    Int J Cardiol; 2013 Oct; 168(4):3527-31. PubMed ID: 23751350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
    Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
    Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
    Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexia.
    Vaughan VC; Sullivan-Gunn M; Hinch E; Martin P; Lewandowski PA
    PLoS One; 2012; 7(9):e45900. PubMed ID: 23029301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
    Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
    Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
    Hare JM; Mangal B; Brown J; Fisher C; Freudenberger R; Colucci WS; Mann DL; Liu P; Givertz MM; Schwarz RP;
    J Am Coll Cardiol; 2008 Jun; 51(24):2301-9. PubMed ID: 18549913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
    Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
    Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.
    Baldus S; Köster R; Chumley P; Heitzer T; Rudolph V; Ostad MA; Warnholtz A; Staude HJ; Thuneke F; Koss K; Berger J; Meinertz T; Freeman BA; Münzel T
    Free Radic Biol Med; 2005 Nov; 39(9):1184-90. PubMed ID: 16214034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase contributes to mechanical ventilation-induced diaphragmatic oxidative stress and contractile dysfunction.
    Whidden MA; McClung JM; Falk DJ; Hudson MB; Smuder AJ; Nelson WB; Powers SK
    J Appl Physiol (1985); 2009 Feb; 106(2):385-94. PubMed ID: 18974366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary inhibition of xanthine oxidase attenuates radiation-induced endothelial dysfunction in rat aorta.
    Soucy KG; Lim HK; Attarzadeh DO; Santhanam L; Kim JH; Bhunia AK; Sevinc B; Ryoo S; Vazquez ME; Nyhan D; Shoukas AA; Berkowitz DE
    J Appl Physiol (1985); 2010 May; 108(5):1250-8. PubMed ID: 20167676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
    Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
    Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
    Saitoh M; Hatanaka M; Konishi M; Ishida J; Palus S; Ebner N; Döhner W; von Haehling S; Anker SD; Springer J
    Int J Cardiol; 2016 Sep; 218():312-317. PubMed ID: 27240157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febuxostat improves outcome in a rat model of cancer cachexia.
    Konishi M; Pelgrim L; Tschirner A; Baumgarten A; von Haehling S; Palus S; Doehner W; Anker SD; Springer J
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):174-80. PubMed ID: 26136193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol.
    Kelley EE; Trostchansky A; Rubbo H; Freeman BA; Radi R; Tarpey MM
    J Biol Chem; 2004 Sep; 279(36):37231-4. PubMed ID: 15231841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.
    Kögler H; Fraser H; McCune S; Altschuld R; Marbán E
    Cardiovasc Res; 2003 Sep; 59(3):582-92. PubMed ID: 14499859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat.
    Sokol RJ; Devereaux MW; Khandwala R
    Pediatr Res; 1998 Sep; 44(3):397-401. PubMed ID: 9727720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.